Runny Nose And Cough
NDC Package 45014-153-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Runny Nose And Cough is do not take more than 4 doses in any 24-hour periodto find right dose, use rotating bottle label to dose by weight; otherwise, use chart below to dose by agespecifically designed for use with enclosed dosing spoon. Marketed by Accudial Pharmaceutical, Inc., this product is identified by NDC 45014-153 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
45014-153-04
Package Description
118 mL in 1 BOTTLE
Product Code
45014-153
11-Digit Billing Format
45014015304
RxNorm Crosswalk
  • RxCUI: 2049286 - brompheniramine maleate 0.5 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 1.25 MG in 5 mL Oral Solution
  • RxCUI: 2049286 - brompheniramine maleate 0.1 MG/ML / dextromethorphan hydrobromide 1 MG/ML / phenylephrine hydrochloride 0.25 MG/ML Oral Solution
  • RxCUI: 2049286 - brompheniramine maleate 0.5 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 1.25 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Runny Nose And Cough
Dosage Form
-
Usage Information
Do not take more than 4 doses in any 24-hour periodto find right dose, use rotating bottle label to dose by weight; otherwise, use chart below to dose by agespecifically designed for use with enclosed dosing spoon. Use only enclosed dosing spoon to dose this product. Do not use any other dosing deviceagedosechildren 6 to under 12 years1½-3 tsp. (7.5-15 mL) every 6 hourschildren under 6 yearsdo not use

Regulatory & Marketing

Labeler Name
Accudial Pharmaceutical, Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
11-04-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45014-153-04 identifies a specific commercial package of 118 ml in 1 bottle of Runny Nose And Cough, labeled by Accudial Pharmaceutical, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Accudial Pharmaceutical, Inc. on November 04, 2009. The current certification is valid through December 31, 2017.

How is this Accudial Pharmaceutical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45014015304. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45014-153-04
11-Digit CMS (5-4-2)
45014-0153-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.